343 related articles for article (PubMed ID: 11283864)
1. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.
Dandri M; Burda MR; Török E; Pollok JM; Iwanska A; Sommer G; Rogiers X; Rogler CE; Gupta S; Will H; Greten H; Petersen J
Hepatology; 2001 Apr; 33(4):981-8. PubMed ID: 11283864
[TBL] [Abstract][Full Text] [Related]
2. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
[TBL] [Abstract][Full Text] [Related]
3. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
[TBL] [Abstract][Full Text] [Related]
4. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice.
Brown JJ; Parashar B; Moshage H; Tanaka KE; Engelhardt D; Rabbani E; Roy-Chowdhury N; Roy-Chowdhury J
Hepatology; 2000 Jan; 31(1):173-81. PubMed ID: 10613743
[TBL] [Abstract][Full Text] [Related]
5. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
6. Near completely humanized liver in mice shows human-type metabolic responses to drugs.
Tateno C; Yoshizane Y; Saito N; Kataoka M; Utoh R; Yamasaki C; Tachibana A; Soeno Y; Asahina K; Hino H; Asahara T; Yokoi T; Furukawa T; Yoshizato K
Am J Pathol; 2004 Sep; 165(3):901-12. PubMed ID: 15331414
[TBL] [Abstract][Full Text] [Related]
7. Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy in haemophilia B.
Tatsumi K; Ohashi K; Kataoka M; Tateno C; Shibata M; Naka H; Shima M; Hisanaga M; Kanehiro H; Okano T; Yoshizato K; Nakajima Y; Yoshioka A
Thromb Haemost; 2008 May; 99(5):883-91. PubMed ID: 18449417
[TBL] [Abstract][Full Text] [Related]
8. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.
Dandri M; Burda MR; Zuckerman DM; Wursthorn K; Matschl U; Pollok JM; Rogiers X; Gocht A; Köck J; Blum HE; von Weizsäcker F; Petersen J
J Hepatol; 2005 Jan; 42(1):54-60. PubMed ID: 15629507
[TBL] [Abstract][Full Text] [Related]
9. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
[TBL] [Abstract][Full Text] [Related]
10. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
[TBL] [Abstract][Full Text] [Related]
11. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.
Ohashi K; Marion PL; Nakai H; Meuse L; Cullen JM; Bordier BB; Schwall R; Greenberg HB; Glenn JS; Kay MA
Nat Med; 2000 Mar; 6(3):327-31. PubMed ID: 10700236
[TBL] [Abstract][Full Text] [Related]
12. GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver.
Masumoto N; Tateno C; Tachibana A; Utoh R; Morikawa Y; Shimada T; Momisako H; Itamoto T; Asahara T; Yoshizato K
J Endocrinol; 2007 Sep; 194(3):529-37. PubMed ID: 17761892
[TBL] [Abstract][Full Text] [Related]
13. Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation.
Dandri M; Burda MR; Gocht A; Török E; Pollok JM; Rogler CE; Will H; Petersen J
Hepatology; 2001 Oct; 34(4 Pt 1):824-33. PubMed ID: 11584382
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
Suemizu H; Hasegawa M; Kawai K; Taniguchi K; Monnai M; Wakui M; Suematsu M; Ito M; Peltz G; Nakamura M
Biochem Biophys Res Commun; 2008 Dec; 377(1):248-52. PubMed ID: 18840406
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen J; Dandri M; Mier W; Lütgehetmann M; Volz T; von Weizsäcker F; Haberkorn U; Fischer L; Pollok JM; Erbes B; Seitz S; Urban S
Nat Biotechnol; 2008 Mar; 26(3):335-41. PubMed ID: 18297057
[TBL] [Abstract][Full Text] [Related]
16. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
Meuleman P; Leroux-Roels G
Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
[TBL] [Abstract][Full Text] [Related]
17. Development of humanized mice for the study of hepatitis C virus infection.
Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
[TBL] [Abstract][Full Text] [Related]
18. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
[TBL] [Abstract][Full Text] [Related]
19. Human hepatocyte propagation system in the mouse livers: functional maintenance of the production of coagulation and anticoagulation factors.
Tatsumi K; Ohashi K; Tateno C; Yoshizato K; Yoshioka A; Shima M; Okano T
Cell Transplant; 2012; 21(2-3):437-45. PubMed ID: 22793051
[TBL] [Abstract][Full Text] [Related]
20. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
